ACUTE ERYTHROBLASTIC LEUKEMIA & TREATMENT
Definition: What is "Acute erythroblastic leukemia"?
Acute erythroblastic leukemia is also known by other medical terms such as erythremic myelosis, erythroleukemia & the DiGuglielmo syndrome, which is the uncontrolled production of immature & undeveloped erythrocytes, more popularly known as the red blood cells. This type of leukemia is a rare form of cancer that originates from the marrow & blood.
Symptoms & Signs
Patients suffering from acute erythroblastic leukemia often experience severe fatigue & weakness. Blood tests would also show less than the average number of white blood cells. Other strong indicators include chills & fever, loss of weight & appetite, easy bruising & bleeding due to the abnormally low platelet levels, joint pains, headaches, confusion & vomiting. Additionally, patients may also show considerable enlargement of the spleen & liver, which can be noticed by the telltale swelling of the abdomen & can be easily detected by doctors in a physical examination.
Treatment: How to Treat "Acute erythroblastic leukemia"?
The treatment for this type of leukemia would largely depend of the cancer cell features presented as well as the extent or severity of the disease, the patient's age, symptoms along with general health condition. Treatment strategies are based on chemotherapies, cell & bone marrow transplantations. Chemotherapies are often administered with the combination of two or more medications.
According to medical records, the causes of this rare form of blood cancer are largely unknown. Nonetheless, acute erythroblastic leukemia actually represents approximately 10-20% of leukemias & secondary to radiation, overexposure to benzene & alkylator theraphy.
Patients who are seeking treatment would usually account some vague history of chronic fatigue. Results from blood tests can easily help establish the diagnosis. An examination of the blood can easily identify abnormal number of red blood cells. Bone marrow examinations should also be performed either through biopsy or aspiration to further examine cell types.